The journey of dostarlimab: a successful weapon for cancer treatment

• Autori principali: Rouchan Ali (Autore), Sharma Arvind Virendra (Autore), Pooja A. Chawla (Autore)
• Natura: Libro
• Pubblicazione: Open Exploration Publishing Inc., 2022-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

In a number of malignancies, new immuno-oncology therapies that focus on the programmed cell death 1 (PD-1) have improvised the patient condition along with a positive aftereffect. Monoclonal antibodies (mAbs) directed against PD-1 and its ligand (PD-L1), have been widely used to treat a variety of...